Keyword Suggestions

Results
 
 
Account Login
 
ACRP User E-mail Address
 
 
 
ACRP Password
 
 
 
 
 

Library Navigation

 
 

Browse Conferences

 
 

Topic Categories

 
 
 
S808 - Dealing with Noncompliance and Mitigating the Risk 
$25.00
Purchase
Date/Time:
April 28, 2014   9:45am - 10:45am
 
CNE credit for this article has expired.
 
Format:
       
  Synced Audio / Video / Slides
 
Share:
 

In the course of the conduct of clinical research, it is inevitable that noncompliance will occur. In some cases, noncompliance can be serious and jeopardize the rights and welfare of research participants. More commonly, however, noncompliance is minor and involves relatively insignificant documentation problems. Investigators, research staff, sponsors and IRBs are obligated to minimize the occurrence of noncompliance as much as possible. This session will define noncompliance in accordance with federal regulations for the protection of human subjects, describe how to investigate allegations of noncompliance using due process, present incident based options institutions and IRBs can take if noncompliance is verified, and discuss FDA and OHRP reporting requirements. Finally, the possible legal consequences of wrongful dismissal or sanctions based upon incomplete and/or faulty determinations of noncompliance will be discussed.

Learning Objectives:
  1. Define serious or continuing noncompliance.
  2. Describe how to investigate allegations of noncompliance using due process.
  3. Explore the possible legal consequences of wrongful dismissal or sanctions based upon incomplete and/or faulty determinations of noncompliance using examples of actual litigations.
 


 
 
Average Rating: (No Ratings)
  Was great, surpassed expectations, and I would recommend this
  Was good, met expectations, and I would recommend this
  Was okay, met most expectations
  Was okay but did not meet expectations
  Was bad and I would not recommend this
 



Submit
 
The 10 Commandments of the Clinical Investigator
Shifting Paradigm Versus Reality of Risk-Based and Remote Monitoring
Monitoring Versus Auditing Versus Inspections: Aren't They All the Same?
The Impact of Risk-Based Monitoring on Clinical Research Sites
Remote Monitoring: How Far Can We Go?